We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Breast intraoperative radiotherapy (IORT) is a partial irradiation technique that delivers a single fraction of radiation dose to the tumour bed during surgery. The use of this technique is increasing (especially in the Middle East), and therefore, it is essential to have a comprehensive approach to this treatment modality. The aim of this study is to conduct a literature review on available IORT modalities during breast irradiation as well as dedicated IORT machines and associated treatment procedures. The main IORT trials and corresponding clinical outcomes are also studied.
Materials and Methods
A computerised search was performed through MEDLINE, PubMed, PubMed Central, ISI web of knowledge and reference list of related articles.
Results
IORT is now feasible through using two main modalities, including low-kilovolt IORT and intraoperative electron radiotherapy (IOERT). The dedicated machines employed and treatment procedure for mentioned modalities are quite different. The outcomes of implemented clinical trials showed that IORT is not inferior to external beam radiotherapy (EBRT) in specifically selected and well-informed patients and can be considered as an alternative to EBRT.
Conclusion
Although the clinical outcomes of introduced IORT methods are comparable, but based on the review results, it could be said that IOERT is the most effective technical method, in view of the treatment time and dose uniformity concepts. The popularity of IORT is mainly due to the distinguished obtained results during breast cancer treatment. Despite the presence of some technical challenges, it is expected that the IORT technique will become more widespread in the immediate future.
This chapter focuses on upper airway imaging, and examines risk factors for obstructive sleep apnea (OSA) (both static and dynamic) and the anatomical factors that are changed when successful treatment modalities are applied. OSA is known to have a significant familial component. Volumetric magnetic resonance imaging (MRI) has been employed to investigate whether or not oropharyngeal soft tissue structures segregate in a familial fashion. These data implicate that changes in airway conformation and the size of structures surrounding the oropharynx are important identifiable risk factors for the development of OSA. Interventions which successfully improve sleep disordered breathing often have positive impacts on these same factors, which may contribute to the reduction in airway collapsibility. Imaging can be used to classify patients for the purpose of targeting treatment modalities in order to enhance the success in treating sleep disordered breathing especially in patients undergoing upper airway surgery.
from
Section B3
-
Promotion of regeneration in the injured nervous system
By
Ken Nakamura, Department of Neurology, University of California, San Francisco, CA,
Un Jung Kang, Department of Neurology, University of Chicago, Chicago, IL, USA
Edited by
Michael Selzer, University of Pennsylvania,Stephanie Clarke, Université de Lausanne, Switzerland,Leonardo Cohen, National Institute of Mental Health, Bethesda, Maryland,Pamela Duncan, University of Florida,Fred Gage, Salk Institute for Biological Studies, San Diego
This chapter examines the rational, therapeutic potential, strategies, and obstacles to the delivery of neurotrophic factors using gene therapy for the treatment of neurologic diseases. Two general approaches are used for gene therapy. In ex vivo approaches, cells are genetically modified in vitro to express relevant genes, and then delivered to target areas. The chapter reviews the application of neurotrophic factor gene therapy to animal models of selected neurologic diseases, in which clinical applications are being investigated. In order to maximize the effectiveness of neurotrophic factors, other components of growth factor signaling pathways such as receptor expression can also be targeted. Even if neurotrophic factors are found to protect against degenerative processes in humans, these protective effects may be unrelated to underlying disease pathophysiology. As a result, there may be continued degeneration that negates any protective effects over time.
This chapter focuses on economic perspectives, and tries to demonstrate how researchers from different disciplines can work together to assist decision makers to formulate mental health policy. Defining the need for treatment is the first requirement, which can be objectively addressed with epidemiological and utilization data on a population-wide basis. From the economic point of view, the purpose of treating mental disorders is to reduce the economic burden of illness on the individual, the family, the community, and on society as a whole. The economic literature has developed three basic methodologies which are used to evaluate the effectiveness of various treatment modalities. These methodologies include: cost-benefit analysis; cost-effectiveness analysis; and cost-utility analysis. Cost comparisons and cost-effectiveness studies in relation to location of care have been undertaken, but more rigorous and complete ones are still required. Cost-benefit, cost-effectiveness, and cost-utility analyses are crucial to decisions about resource allocation in medical care.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.